Zydus Lifesciences Ltd. Financials: Quarterly Results
Revenue
6891.8
Cr.
PAT
965.10
Cr.
EBITDA
1568.20
Cr.
Zydus Lifesciences Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 6780.40 | 6037.90 | 6467 | 6290.20 | 5123.50 |
| Total Income From Operations (Cr.) | 6864.50 | 6123.20 | 6573.70 | 6527.90 | 5269.10 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 1568.20 | 1822.90 | 2005.30 | 1968.20 | 1216.10 |
| P/L Before Exceptional Items & Tax (Cr.) | 1438.30 | 1721.60 | 1920.60 | 1891.60 | 1184.10 |
| P/L After Tax from Ordinary Activities (Cr.) | 965.10 | 1233.40 | 1486.60 | 1248.80 | 1004.60 |
| Net Profit/Loss For the Period (Cr.) | 965.10 | 1233.40 | 1486.60 | 1248.80 | 1004.30 |
| Basic EPS | 10.36 | 12.51 | 14.58 | 11.64 | 10.17 |
FAQs
Zydus Lifesciences Ltd. announced its quarterly results for Q3 FY2026 on February 9, 2026.
In Q3 FY2026, Zydus Lifesciences Ltd. are as follows:
Revenue: ₹6891.8 crore
Net Profit: ₹965.10 crore.
For Q3 FY2026, Zydus Lifesciences Ltd. posted ₹6891.8 crore in revenue and ₹965.10 crore in net profit.
Past quarterly results for Zydus Lifesciences Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.